Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma? - Wikidata - awgldk - TriplyDB

Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?

Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?

http://www.wikidata.org/entity/Q39546902

about

Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.Genotoxicity in Mice Following AAV Gene Delivery: A Safety Concern for Human Gene Therapy?Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectors TALEN/CRISPR-mediated engineering of a promoterless anti-viral RNAi hairpin into an endogenous miRNA locus.Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies Gene editing technology as an approach to the treatment of liver diseases.Adeno-Associated Virus Gene Therapy for Liver Disease.Cell and gene therapy strategies to eradicate HIV reservoirs Plasmodium meets AAV-the (un)likely marriage of parasitology and virology, and how to make the match.Current and future prospects for hemophilia gene therapy.Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention.Identification of liver-specific enhancer-promoter activity in the 3' untranslated region of the wild-type AAV2 genome.AAV Infection: Protection from Cancer.Blocking sense-strand activity improves potency, safety and specificity of anti-hepatitis B virus short hairpin RNA.Development of an AAV9 coding for a 3XFLAG-TALEfrat#8-VP64 able to increase in vivo the human frataxin in YG8R mice.Dystrophin Gene Replacement and Gene Repair Therapy for Duchenne Muscular Dystrophy in 2016: An Interview.Reply to "Wild-type AAV Insertions in Hepatocellular Carcinoma Do Not Inform Debate Over Genotoxicity Risk of Vectorized AAV"Lessons learned from lung and liver in-vivo gene therapy: implications for the future AAVvector-mediated in vivo reprogramming into pluripotency

P2860

Q33881920-BE35538C-C8A5-4F43-B558-BDDA53BBC8BC Q36756903-655B9A28-7CE8-4A0D-A99C-90480EC5BFD2 Q36867801-EEAEBD9A-0196-4822-B49D-B9E849FC6CDA Q37577414-D7061481-8AF3-44D7-8722-1C981878F422 Q37621530-70F975D0-9C02-4AD7-A1FC-1BD6660CFA09 Q38749884-1DF80D50-5BB0-43C5-A893-F69AD9A82F2C Q38789554-66AF742C-8B68-4E94-A2F7-83E19A147026 Q38794293-61B3049C-E86E-4C13-9F84-BB6BEB5AE6DF Q38818422-5D6A4D9F-1B5D-4705-BB05-6E6D26F1598C Q38827606-3C92E584-F6AE-4B9B-90E9-49E203DDD088 Q39108774-BDF5F2C8-46D1-4A0B-8D9C-95A8024BFC19 Q40154601-C908D62E-CB8E-4B11-8CB5-627E5AD6DCF3 Q40457152-D81D2686-806F-4E55-95D7-1512223740AD Q40595052-DE3BA25D-B63B-4C7F-BABD-D70B58081DB5 Q40798280-F6E36A20-7385-487C-A26F-64E36513DE72 Q42561764-09ADC0E8-4F89-429E-ABC9-A3131647C8F5 Q42749763-FD8CFA6A-815B-450E-AA97-2036C3ADE3F0 Q57163666-15BEAA26-868C-4ED4-BA61-1ECF32C4DDDE Q57562597-C4C0F07F-FD23-4EA2-BE86-A15EDE45BB4B

P2860

Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?

http://www.wikidata.org/entity/Q39546902

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?

@en

Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?

@nl

type

label

Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?

@en

Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?

@nl

prefLabel

Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?

@en

Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?

@nl

P1433

Q39546902-4F65B0FF-01D1-4CDC-AF83-9242FDB51B92

P1476

Q39546902-081DF1E5-08CF-4B0C-8BD3-8F94A14E125A

P2093

Q39546902-0674068F-FB00-4764-9A54-F1133376D985

Q39546902-3EBDF5AC-09CD-490A-BFF3-13327F35C01B

Q39546902-3F09E189-9DDE-4470-8BA8-0415560F2C3E

Q39546902-506C8DA4-5E47-4BAE-8652-88217C513E5A

Q39546902-58797559-EAE8-4B09-A27B-C2EEAF1DEB7E

Q39546902-62887D66-8481-4458-86CC-7E7AE23D4214

Q39546902-92F8D165-D797-461F-A18A-EA79E9417E55

Q39546902-A357A471-C40E-4E1C-B780-315C225417D8

Q39546902-DF2CB643-1FBF-438E-93C4-6B72D6BD4FBC

Q39546902-F67E81B6-B7EE-4BE2-B182-8BC303BC1F65

P2860

Q39546902-15444B5C-9836-43C0-A003-0FA076AF3F7E

Q39546902-1A6D2422-967B-46BF-8F51-860D5D90A91C

Q39546902-3EF65394-E1CB-4150-9020-66F7F281D982

Q39546902-3F2BCDB4-42FB-4FE6-AE26-04E36C2F5FA6

Q39546902-44F2C8E2-CFFA-463E-A148-DA811CF27CF7

Q39546902-4D4E3B40-F089-4126-B5E7-4A0F0E0125A2

Q39546902-5AE5BC46-F2AF-45C3-8E94-D92CC06F6DBD

Q39546902-65CB3B58-1197-475A-AF37-0A29AD4CE70C

Q39546902-706BD0AD-7DE1-4D86-9E88-7216A2FDB62A

Q39546902-84DDC0F9-2C60-4477-9BB1-294A4B25D8A1

P304

Q39546902-ABFD5CD0-10D3-42B7-9E26-614B3209A77D

P31

Q39546902-284B9DCA-873C-4256-B949-ECBA5C77D21B

P356

Q39546902-ED8D7C18-C6D8-457C-BCBE-C8317C3A4C3B

P433

Q39546902-AE86A7CD-2587-4C88-BA2E-32340A3298CC

P478

Q39546902-D55B6647-9D65-4EE9-8212-A2A9C8ECFF7F

P50

Q39546902-98F8161A-4E75-422E-96E1-F1F266ABA520

P577

Q39546902-8C7AF1CD-8FAD-40A3-8AC2-45184D1465B7

P5875

Q39546902-8400B8CF-F8D2-4CE7-A68B-01D447367860

P698

Q39546902-9E9A09AC-403C-4200-BF26-C0AF0EBD3A27

P932

Q39546902-332E0CBD-9515-4ED6-B802-1D980FBFD013

P356

HUM.2015.29014.KIB

P1433

Human Gene Therapy

P1476

Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?

@en

P2093

Arun Srivastava

http://www.w3.org/2001/XMLSchema#string

Barry J Byrne

http://www.w3.org/2001/XMLSchema#string

Guangping Gao

http://www.w3.org/2001/XMLSchema#string

Kenneth I Berns

http://www.w3.org/2001/XMLSchema#string

Nicholas Muzyczka

http://www.w3.org/2001/XMLSchema#string

Roland W Herzog

http://www.w3.org/2001/XMLSchema#string

Sergei Zolotukhin

http://www.w3.org/2001/XMLSchema#string

Terence R Flotte

http://www.w3.org/2001/XMLSchema#string

Thierry VandenDriessche

http://www.w3.org/2001/XMLSchema#string

Xiao Xiao

http://www.w3.org/2001/XMLSchema#string

P2860

Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success--a personal perspective

Translational data from adeno-associated virus-mediated gene therapy of hemophilia B in dogs

Assessing the potential for AAV vector genotoxicity in a murine model.

Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy.

Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity

Efficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors.

World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma.

Effect of adeno-associated virus on cancer expression by herpesvirus-transformed hamster cells.

Antibodies to adeno-associated satellite virus and herpes simplex in sera from cancer patients and normal adults.

Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.

P304

779-781

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/HUM.2015.29014.KIB

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

William W Hauswirth

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

287797271

http://www.w3.org/2001/XMLSchema#string

P698

26690810

http://www.w3.org/2001/XMLSchema#string

P932

4809064

http://www.w3.org/2001/XMLSchema#string